Spreadsheet: 8ae389b0-1c63-4128-95fd-6255741776e2
Sheet: Sheet1

Test Referenced | Entry Type | Mayo ID | Description | Reporting Description | Method | Collection Container | Temperature | Stability | [NAME] | Unit of Measure | [NAME] | Minimum Volume | Reject Due To | Reference Values | Days/Times Performed | Analytic Time | Maximum Lab Time | CPT Units | CPT Code | LOINC® Code | LOINC® Attributes | Always Performed | Orderable Separately | Performing Location
FBNN | Test | FBNN | FBN1, Partial [NAME], Neonatal Marfan Syndrome | Neonatal Marfan Syndrome, [NAME] | Polymerase Chain Reaction (PCR) Followed by DNA Sequence Analysis (PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.) | Lavender-top (EDTA) Tube: EDTA |  |  | 3 | mL | Multiple cardiovascular-related gene sequencing tests can be performed on a single specimen after a single extraction. See Multiple Cardiovascular-Related Gene Sequencing Tests in Special Instructions for a list of tests that can be ordered together.  Container/Tube: Lavender top (EDTA) [NAME]: 3 mL Collection Instructions: Send specimen in original tube. Additional Information: 1. Include physician name and phone number with the specimen. 2. Transfusions will interfere with testing for up to 4 to 6 weeks. DNA obtained from white cells may not provide useful information for patients who received a recent transfusion of blood that was not leukocyte-reduced. Wait 4 to 6 weeks until transfused cells have left the patient's circulation before drawing the patient's blood specimen for genotype testing. Forms:  1. FBN1/TGFBR2/TGFBR1 Gene Testing Patient Information Sheet (Supply T636) in Special Instructions 2. New York Clients-Informed consent is required. Please document on the request form or electronic order that a copy is on file. An Informed Consent for Genetic Testing (Supply T576) is available in Special Instructions. | 0.5 mL | Hemolysis	NA Thawing	Warm reject; Cold reject Lipemia	NA Icterus	NA Other	NA | An interpretive report will be provided. | Varies | 7 days | 14 days | 1 | 81479 |  |  |  |  | Rochester
FBNN | [NAME] | WBEDTA | [NAME] EDTA |  |  |  | Ambient
FBNN | Component | FBNNP | Neonatal Marfan Syndrome, [NAME] | Neonatal Marfan Syndrome, [NAME] | Polymerase Chain Reaction (PCR) Followed by DNA Sequence Analysis (PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.) Only orderable as part of a profile. For further information see #89314 "FBN1, Partial [NAME], Neonatal Marfan Syndrome." |  |  |  |  |  | Draw blood in a lavender-top EDTA tube(s), and send 3 mL of EDTA whole blood ambient. Only orderable as part of a profile. For further information see #89314 "FBN1, Partial [NAME], Neonatal Marfan Syndrome." | 0.5 mL |  | Only orderable as part of a profile. For further information see #89314 "FBN1, Partial [NAME], Neonatal Marfan Syndrome." |  |  |  |  |  |  |  | Yes | No
FBNNP | [NAME] | WBEDTA | [NAME] EDTA |  |  |  | Ambient
FBNNP | Result | 29301 | FBN1 Neonatal Result | FBN1 Neonatal Result | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
FBNNP | Result | 45484 | FBN1 Neonatal Interpretation | FBN1 Neonatal Interpretation | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 69047-9
FBNNP | Result | 45485 | Reviewed By | Reviewed By | Numeric
FBNN | Component | FBNNS | FBN1 Neonatal Screen Sequencing | FBN1 Neonatal Screen Sequencing | Only orderable as part of a profile. For further information see FBNN/89314 FBN1, Partial [NAME], Neonatal Marfan Syndrome. |  |  |  |  |  | Only orderable as part of a profile. For further information see FBNN/89314 FBN1, Partial [NAME], Neonatal Marfan Syndrome. |  |  | Only orderable as part of a profile. For further information see FBNN/89314 FBN1, Partial [NAME], Neonatal Marfan Syndrome. |  |  |  |  |  |  |  | Yes | No
FBNNS | [NAME] | WBEDTA | [NAME] EDTA |  |  |  | Ambient
FBNNS | Result | FBNNS | FBN1 Neonatal Screen Sequencing | FBN1 Neonatal Screen Sequencing | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 40471-5